A phase 2 study of MK-0457 in patients with BCR-ABL T315I mutant chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.
Seymour JF, Kim DW, Rubin E, Haregewoin A, Clark J, Watson P, Hughes T, Dufva I, Jimenez JL, Mahon FX, Rousselot P, Cortes J, Martinelli G, Papayannidis C, Nagler A, Giles FJ.
Seymour JF, et al. Among authors: cortes j.
Blood Cancer J. 2014 Aug 15;4(8):e238. doi: 10.1038/bcj.2014.60.
Blood Cancer J. 2014.
PMID: 25127392
Free PMC article.
Clinical Trial.